World Journal of Dermatology最新文献

Systematic review of hematidrosis: Time for clinicians to recognize this entity 血液病的系统回顾:是时候让临床医生认识到这个实体了

World Journal of Dermatology Pub Date : 2023-02-06 DOI: 10.5314/wjd.v11.i2.7

G. Octavius, Fellisa Meliani, R. Heriyanto, T. Yanto

引用次数: 0

Generalized prurigo nodularis with dramatic response to dupilumab treatment: A case report 广泛性结节性痒疹对dupilumab治疗的显著反应:1例报告

World Journal of Dermatology Pub Date : 2023-01-16 DOI: 10.5314/wjd.v11.i1.1

C. Boyvadoglu, H. S. Inaloz

引用次数: 0

Connection between dermatomyositis and montelukast sodium use: A case report 皮肌炎与孟鲁司特钠使用的关系:1例报告

World Journal of Dermatology Pub Date : 2022-09-02 DOI: 10.5314/wjd.v10.i2.10

Mohammed Aly, A. Alshehri, Abdelgaffar Mohammed, Murouj Almaghrabi, Malek M Alharbi

{"title":"Connection between dermatomyositis and montelukast sodium use: A case report","authors":"Mohammed Aly, A. Alshehri, Abdelgaffar Mohammed, Murouj Almaghrabi, Malek M Alharbi","doi":"10.5314/wjd.v10.i2.10","DOIUrl":"https://doi.org/10.5314/wjd.v10.i2.10","url":null,"abstract":"BACKGROUND Montelukast or Singulair is a leukotriene receptor antagonist that reduces inflammation and relaxes the smooth muscles. It is known to be a safe and tolerable drug; nevertheless, it might be associated with several mild to severe adverse effects, one of which is dermatomyositis. Dermatomyositis is a rare acquired autoimmune myositis of unknown cause affecting adults and children. The literature has infrequently reported the association between dermatomyositis and montelukast use. CASE SUMMARY The current study reports a case of a 48-year-old black woman with a previous history of bronchial asthma and allergic rhinosinusitis who presented with typical signs and symptoms of dermatomyositis which were confirmed by investigations. Before developing dermatomyositis, the patient was prescribed montelukast for atopy and consumed the drug for five months. After administration of prednisolone, the patient had a significant improvement and is still being followed up. CONCLUSION Even though montelukast is widely used and believed to be a safe drug for managing several conditions, the present case report highlights the possibility of adverse effects of montelukast. Therefore, future studies with advanced study designs are highly recommended to investigate the association between dermatomyositis and montelukast use. Aly MH et al. Dermatomyositis and montelukast sodium use WJD https://www.wjgnet.com 11 September 2, 2022 Volume 10 Issue 2","PeriodicalId":247332,"journal":{"name":"World Journal of Dermatology","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115803966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Platelet-rich plasma application in diabetic ulcers: A review 富血小板血浆在糖尿病溃疡中的应用综述

World Journal of Dermatology Pub Date : 2022-06-02 DOI: 10.5314/wjd.v10.i1.1

Victoria Pereira Simão, Carolina Souza Cury, Gabriel Mota Zamariolli Tavares, Gabriel Calixto Ortega, Arthur Cichetto Ribeiro, G. Santos, J. F. Lana

引用次数: 0